Literature DB >> 34148616

Field carcinogenesis for risk stratification of colorectal cancer.

Dionne Rebello1, Elliott Rebello2, Matthew Custodio3, Xixi Xu3, Sanil Gandhi4, Hemant K Roy5.   

Abstract

Colorectal cancer (CRC) is characterized by genetic-environmental interplay leading to diffuse changes in the entire colonic mucosa (field carcinogenesis or field of injury) and to a pro-neoplastic genetic/epigenetic/physiological milieu. The clinical consequences are increased risk of synchronous and metachronous neoplasia. Factors such as genetics, race, ethnicity, age, and socioeconomic status are thought to influence neoplasia development. Here, we explore the potential improvement to CRC screening through exploiting field carcinogenesis, with particular focus on racial disparities and chemoprevention strategies. Also, we discuss future directions for field carcinogenesis/risk stratification using molecular and novel biophotonic techniques for personalized CRC screening.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biophotonics; Chemoprevention; Colorectal cancer; Field carcinogenesis; Field defect; Field effect; Risk stratification; Screening

Mesh:

Year:  2021        PMID: 34148616     DOI: 10.1016/bs.acr.2021.03.004

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  2 in total

1.  Nanomolar EP4 receptor potency and expression of eicosanoid-related enzymes in normal appearing colonic mucosa from patients with colorectal neoplasia.

Authors:  Ulrike Ries Feddersen; Sebastian Kjærgaard Hendel; Mark Alexander Berner-Hansen; Thomas Andrew Jepps; Mark Berner-Hansen; Niels Bindslev
Journal:  BMC Gastroenterol       Date:  2022-05-12       Impact factor: 2.847

2.  LncRNA LINC02257: A Potential Biomarker for Diagnosis and Prognosis of Colorectal Cancer.

Authors:  Mei Chen; Changbing Li; Qinghua Luo; Anhui Tan
Journal:  J Oncol       Date:  2022-09-10       Impact factor: 4.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.